Back
Hermes International SA Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
42
HESAY
Hermes International SA
Last Price:
$269.41
Seasonality Move:
11.23%
Buy
55
SRPT
Sarepta Therapeutics
Last Price:
$97.77
Seasonality Move:
6.73%
Sell
42
Hermes International SA (HESAY)
is a Sell
Is Hermes International SA a Buy, Sell or Hold?
-
The current Hermes International SA [HESAY] share price is $271.78. The Score for HESAY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
HESAY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HESAY Stock Price Chart
What is Hermes International SA's stock price today?
-
The Hermes International SA share price today is $271.78Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HESAY is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $99.77Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
HESAY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.76 | Buy |
Relative Strength Index (14 RSI): | 42.21 | Sell |
Chaikin Money Flow: | -26364 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (278.04 - 291.88) | Sell |
Bollinger Bands (100): | (221.1 - 275.02) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.4 | Sell |
Relative Strength Index (14 RSI): | 37.2 | Sell |
Chaikin Money Flow: | -420668 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (103.16 - 112.22) | Sell |
Bollinger Bands (100): | (109.63 - 127.19) | Sell |
HESAY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 280.33 | Sell |
20-day SMA: | 285.66 | Sell |
50-day SMA: | 270.02 | Buy |
200-day SMA: | 238.77 | Buy |
8-day EMA: | 278.52 | Sell |
20-day EMA: | 280.93 | Sell |
50-day EMA: | 270.99 | Buy |
200-day EMA: | 244.87 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 103.49 | Sell |
20-day SMA: | 106.07 | Sell |
50-day SMA: | 113.88 | Sell |
200-day SMA: | 126.52 | Sell |
8-day EMA: | 103.1 | Sell |
20-day EMA: | 106.21 | Sell |
50-day EMA: | 111.8 | Sell |
200-day EMA: | 120.79 | Sell |
Hermes International SA Earnings Growth & HESAY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.
Hermes International SA Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |